Monoclonal Antibody News and Research

RSS
Monoclonal antibodies (MAbs) are produced from a single B cell clone and can bind to a single type of antigen binding site. MAbs are homogenous antibodies that cannot form lattices with monomeric proteins as they can bind to only a single epitope on the antigen. Developed in the 1970s, MAbs can be produced against any given substance. Thus they can be used to detect and purify any substance of interest. This has made MAbs a powerful tool of molecular biology, biochemistry, and medicine.
Genetic modification in the ‘coat’ of fatal brain virus may allow it to escape antibodies

Genetic modification in the ‘coat’ of fatal brain virus may allow it to escape antibodies

Mutations in SARS-CoV-2 spike protein may improve monoclonal antibody resistance

Mutations in SARS-CoV-2 spike protein may improve monoclonal antibody resistance

Researchers map molecular structure of CV30 antibody to neutralize coronavirus

Researchers map molecular structure of CV30 antibody to neutralize coronavirus

New radioimmunotherapy effectively reverses resistance to lymphoma therapy

New radioimmunotherapy effectively reverses resistance to lymphoma therapy

Researchers identify an effective treatment for severe cases of COVID-19 infection

Researchers identify an effective treatment for severe cases of COVID-19 infection

Researchers discover antibodies that may provide effective immunity against SARS-CoV-2

Researchers discover antibodies that may provide effective immunity against SARS-CoV-2

A genetic link discovered to predict treatment response for patients with rare, aggressive cancer

A genetic link discovered to predict treatment response for patients with rare, aggressive cancer

NIH clinical study to evaluate potential new therapeutics for mild, moderate COVID-19

NIH clinical study to evaluate potential new therapeutics for mild, moderate COVID-19

A simple screening process may improve mAb-based drug development

A simple screening process may improve mAb-based drug development

Rapid drug development yields potential treatment for yellow fever

Rapid drug development yields potential treatment for yellow fever

NIH establishes clinical trial network to test vaccines and monoclonal antibodies for COVID-19

NIH establishes clinical trial network to test vaccines and monoclonal antibodies for COVID-19

Scientists discover role of surface diffusion in protein transport

Scientists discover role of surface diffusion in protein transport

NJIT researchers develop new efficient method to quantify therapeutic proteins

NJIT researchers develop new efficient method to quantify therapeutic proteins

Researchers identify antibody cocktail with potential to neutralize SARS-CoV-2 virus

Researchers identify antibody cocktail with potential to neutralize SARS-CoV-2 virus

Cross-neutralization of SARS and COVID-19 coronaviruses by an antibody

Cross-neutralization of SARS and COVID-19 coronaviruses by an antibody

Study shows coronavirus does not induce cross-protective immune antibodies

Study shows coronavirus does not induce cross-protective immune antibodies

Discovery Of Antibody That Blocks Infection Of SARS-Cov-2

Discovery Of Antibody That Blocks Infection Of SARS-Cov-2

Beta Cells From Stem Cells

Beta Cells From Stem Cells

Discovery marks a critical step toward developing new anti-cancer drugs

Discovery marks a critical step toward developing new anti-cancer drugs

IL-2's flexible structure helping the immune system

IL-2's flexible structure helping the immune system